Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?

To: Marty who wrote (680)	6/7/1999 3:42:00 PM
From: john jansen	Read Replies (1) \| Respond to of 705

Different schools it is but that is k im here for the long term and for the short term the fun or the excitement of the day traders and now looking at the big investers buy in volume!they buy up to 5-600 shares at a time even 1000 a day how much fun can i have! I will miss the stockholder meeting hope someone reports on it want Summary of the smiles of directors and management. Could be FDA may have news they should have concluded phase 2 by now. Should we hire the Gov. of Minn to run around wall street and the FDA and wake everyone up- he has lots of free time! LETS GO!!!

To: Marty who wrote (680)	7/11/1999 1:30:00 PM
From: Marty	Read Replies (2) \| Respond to of 705

Last month I posted an view that "Big institutions can't take a position in a company with so few shares outstanding. Getting more shares in the float makes NEOT eligible for institutions that may have wanted to take a position but couldn't with so few shares in the float. Even so, NEOT will still have fewer shares in the float after the secondary offering than most other comparable companies" Now I find a kindred spirit in a fund manager, who says pretty much the same thing in a new article. beta.siliconinvestor.com Basically, the article says that "Kern argues that one of the reasons fund managers have been cool toward smaller stocks is the difficulty of buying or selling the shares in quantity without affecting the price. But now institutional investors have come to embrace the secondary as a way to buy the stock in size." The more I think about it, the more I think that the secondary is going to be a very good thing for the company. I'd rather own one ten millionth share of a pie worth 50 million dollars bigger than the pie I had a one six and a half millionth share of. Which is kind of a convoluted way of looking at it (and saying it) but the math is good.